GO:0005391 P-type sodium:potassium-exchanging transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005391 describes the molecular function of the Na+/K+-ATPase, an enzyme that uses ATP to pump three sodium ions out of the cell and two potassium ions in, maintaining electrochemical gradients essential for cell volume, resting potential, and secondary active transport.
• The Na+/K+-ATPase is a P-type ATPase that undergoes phosphorylation and conformational changes (E1/E2 states) during its catalytic cycle, a mechanism conserved across P-type pumps.
• It is a heterodimer of an alpha subunit (ATP1A1-4) containing the catalytic site and a beta subunit (ATP1B1-3) required for maturation and membrane insertion; a regulatory gamma subunit (FXYD proteins) modulates activity.
• Dysfunction or dysregulation of the Na+/K+-ATPase is linked to neurological disorders, cardiovascular diseases, and cancer, making it a target for experimental models.
• Studying GO:0005391 requires methods such as ATPase activity assays, patch-clamp electrophysiology, and CRISPR-based gene editing to dissect subunit-specific functions.
• CRISPR knockout, point mutation, and knock-in models of ATP1A1, ATP1B1, and related genes enable precise investigation of the pump's role in health and disease.
Description
The P-type sodium:potassium-exchanging transporter activity (GO:0005391) is a fundamental molecular function carried out by the Na+/K+-ATPase, also known as the sodium pump. This enzyme couples the hydrolysis of ATP to the exchange of sodium and potassium ions across the plasma membrane, a process critical for maintaining ionic gradients that underlie cell volume regulation, resting membrane potential, and nutrient transport. The Na+/K+-ATPase is a member of the P-type ATPase family, characterized by the formation of a phosphorylated intermediate during its catalytic cycle. Since its discovery, the Na+/K+-ATPase has been recognized as a key player in physiology and disease, with roles extending from muscle contraction to neuronal signaling. Research into this GO term spans biochemistry, structural biology, and genetics, offering insights into how cells manage energy and ion homeostasis. Understanding GO:0005391 is therefore essential for researchers studying membrane transport, cellular excitability, and related pathologies.
P-type sodium:potassium-exchanging transporter activity At A Glance
| GO ID | GO:0005391 |
|---|---|
| GO term | P-type sodium:potassium-exchanging transporter activity |
| Ontology | molecular_function |
| Synonym | Na+/K+-ATPase activity; sodium pump; Na,K-activated ATPase activity; sodium/potassium-transporting ATPase activity |
| Major function | ATP-dependent exchange of Na+ and K+ across membranes, maintaining electrochemical gradients |
| Reaction | ATP + H2O + Na+(in) + K+(out) = ADP + phosphate + Na+(out) + K+(in) |
| Cofactors | Magnesium ions (Mg2+) are required for ATP hydrolysis |
| Localization | Plasma membrane of most animal cells |
| Subunits | Alpha (catalytic), beta (regulatory), and gamma (FXYD) subunits |
What Is GO:0005391?
GO:0005391, P-type sodium:potassium-exchanging transporter activity, is defined as the transfer of solutes across a membrane according to the reaction: ATP + H2O + Na+(in) + K+(out) = ADP + phosphate + Na+(out) + K+(in). In simpler terms, it is the enzymatic activity of the Na+/K+-ATPase, which uses energy from ATP to pump sodium ions out of the cell and potassium ions into the cell, against their concentration gradients. This activity is a hallmark of P-type ATPases, which form a phosphorylated intermediate during the transport cycle.
Why Is P-type sodium:potassium-exchanging transporter activity Important in Cell Biology?
The Na+/K+-ATPase is indispensable for life, as it maintains the resting membrane potential and ionic gradients that drive essential processes such as nerve impulse transmission, muscle contraction, and nutrient uptake. Its activity accounts for a significant portion of cellular energy consumption, and its dysfunction is implicated in a wide range of diseases, including hypertension, heart failure, and neurological disorders. Moreover, the Na+/K+-ATPase is a target for cardiac glycosides like digoxin, used in heart failure treatment, highlighting its pharmacological relevance. Understanding GO:0005391 at the molecular level is therefore crucial for both basic biology and therapeutic development.
• Maintains resting membrane potential and cell volume in all animal cells.
• Provides the driving force for secondary active transport of nutrients and ions.
• Regulates extracellular potassium concentration, critical for muscle and nerve function.
• Its dysfunction is linked to neurological disorders such as alternating hemiplegia of childhood.
• Involved in cardiovascular diseases, including hypertension and heart failure.
• Plays a role in cancer cell proliferation and survival, making it a potential therapeutic target.
• Targeted by cardiac glycosides (e.g., digoxin) for heart failure treatment.
• Serves as a model system for studying P-type ATPase mechanism and ion transport.
• Essential for kidney function and sodium reabsorption.
• Its activity is modulated by hormones, ions, and oxidative stress.
What Happens During P-type sodium:potassium-exchanging transporter activity?
Ion Binding and Phosphorylation
In simple terms: The pump grabs sodium ions inside the cell and uses ATP to add a phosphate group to itself.
The catalytic cycle begins with the binding of three intracellular Na+ ions to the alpha subunit of the Na+/K+-ATPase. This binding triggers the phosphorylation of a conserved aspartate residue by ATP, forming a high-energy acyl phosphate intermediate. This step is characteristic of P-type ATPases and requires Mg2+ as a cofactor. The phosphorylation induces a conformational change from the E1 to the E2 state, occluding the Na+ ions within the protein.
Conformational Change and Ion Release
In simple terms: The pump changes shape, releasing sodium outside and then picking up potassium from outside.
In the E2 state, the affinity for Na+ decreases, and the ions are released into the extracellular space. Simultaneously, the affinity for K+ increases, allowing two extracellular K+ ions to bind to the pump. This exchange is driven by the energy stored in the phosphorylated intermediate. The binding of K+ stimulates dephosphorylation, returning the pump to the E1 state.
Dephosphorylation and K+ Release
In simple terms: The pump releases potassium inside the cell and resets itself to start over.
Dephosphorylation of the aspartate residue occurs upon K+ binding, completing the transport cycle. The two K+ ions are released into the cytoplasm, and the pump returns to its original E1 conformation, ready for another cycle. This cycle is highly efficient, with each ATP hydrolyzed resulting in the transport of three Na+ out and two K+ in, contributing to the electrogenic nature of the pump.
Regulation by Subunits and Modulators
In simple terms: Other proteins and small molecules can tweak how fast or slow the pump works.
The Na+/K+-ATPase is a heterodimer of alpha and beta subunits, and its activity is further modulated by FXYD proteins (gamma subunits). The beta subunit is essential for proper folding and delivery of the alpha subunit to the plasma membrane. FXYD proteins can alter the pump's affinity for Na+ and K+ in a tissue-specific manner. Additionally, oxidative stress, such as H2O2, can affect pump activity by modifying critical residues.
Key Genes Involved in GO:0005391 P-type sodium:potassium-exchanging transporter activity
The following genes encode subunits and regulators of the Na+/K+-ATPase (GO:0005391) and are commonly studied in research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP1A1 | Alpha-1 catalytic subunit; ubiquitous Na+/K+-ATPase | Mutations linked to hypertension and neurological disorders |
| ATP1A2 | Alpha-2 catalytic subunit; mainly in muscle and glia | Mutations cause familial hemiplegic migraine and alternating hemiplegia |
| ATP1A3 | Alpha-3 catalytic subunit; neurons | Mutations associated with rapid-onset dystonia-parkinsonism |
| ATP1A4 | Alpha-4 catalytic subunit; testis and sperm | Role in sperm motility; potential contraceptive target |
| ATP1B1 | Beta-1 subunit; widely expressed | Required for pump maturation; mutations cause seizures |
| ATP1B2 | Beta-2 subunit; glial cells | Involved in neuronal-glial interactions |
| ATP1B3 | Beta-3 subunit; testis and other tissues | Associated with cancer progression |
| FXYD1 | Gamma subunit (phospholemman); heart and muscle | Regulates pump activity in cardiac tissue |
| FXYD2 | Gamma subunit; kidney | Mutations cause hypomagnesemia |
| FXYD3 | Gamma subunit; various epithelia | Overexpressed in some cancers |
| FXYD4 | Gamma subunit; kidney | Modulates sodium reabsorption |
| FXYD5 | Gamma subunit; widespread | Linked to cell adhesion and cancer |
| FXYD6 | Gamma subunit; brain | Potential role in psychiatric disorders |
| FXYD7 | Gamma subunit; brain | Modulates neuronal excitability |
| ATP1A1 (isoform) | Catalytic subunit variants | Isoform-specific functions in different tissues |
| ATP1B1 (isoform) | Beta subunit variants | Isoform-specific regulation |
| ATP1A2 (isoform) | Catalytic subunit variants | Isoform-specific functions |
How Is P-type sodium:potassium-exchanging transporter activity Regulated?
The activity of the Na+/K+-ATPase (GO:0005391) is tightly regulated at multiple levels. Short-term regulation involves phosphorylation by protein kinases (e.g., PKA, PKC) and interaction with FXYD proteins, which modulate ion affinity and pump turnover. Long-term regulation includes changes in gene expression of ATP1A and ATP1B subunits in response to hormones (e.g., aldosterone, thyroid hormone) and physiological demands. Oxidative stress, such as H2O2, can reversibly inhibit pump activity by oxidizing critical cysteine residues. Additionally, iron overload has been shown to impact P-type ATPases, including the Na+/K+-ATPase, suggesting a role in iron-related pathologies.
P-type sodium:potassium-exchanging transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP1A2 | Familial hemiplegic migraine | Knock-in mouse with patient mutation |
| ATP1A3 | Alternating hemiplegia of childhood | CRISPR knock-in of D801N mutation in mice |
| ATP1A1 | Hypertension, cancer | Knockout or overexpression in cell lines |
| FXYD2 | Hypomagnesemia | Knockout mouse model |
| ATP1B1 | Seizures, neurological disorders | Conditional knockout in neurons |
Neurological Disorders
Mutations in ATP1A2 and ATP1A3, encoding alpha subunits of the Na+/K+-ATPase, are associated with familial hemiplegic migraine, alternating hemiplegia of childhood, and rapid-onset dystonia-parkinsonism. These mutations often impair pump activity or trafficking, leading to neuronal hyperexcitability and altered ion homeostasis. Research using knock-in mouse models has provided insights into disease mechanisms.
Cardiovascular Diseases
The Na+/K+-ATPase is the receptor for cardiac glycosides like digoxin, which inhibit its activity and are used to treat heart failure. Dysregulation of pump activity in cardiac and vascular tissues contributes to hypertension and cardiac hypertrophy. Oxidative stress, a common feature of cardiovascular disease, can further modulate pump function.
Cancer
Altered expression and activity of Na+/K+-ATPase subunits, particularly ATP1A1 and ATP1B1, have been observed in various cancers, where they can influence cell proliferation, migration, and apoptosis. Some FXYD proteins, such as FXYD3 and FXYD5, are overexpressed in tumors and correlate with poor prognosis. Targeting the pump with cardiac glycosides is being explored as an anticancer strategy.
From P-type sodium:potassium-exchanging transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ATP1A1 knockout on cell viability? | CRISPR knockout in HeLa or HEK293 cells |
| How does a specific ATP1A3 mutation affect pump function? | Point mutation knock-in in iPSC-derived neurons |
| What is the role of ATP1B1 in neuronal development? | Conditional knockout mouse |
| Can overexpression of FXYD1 rescue cardiac dysfunction? | Transgenic overexpression in mouse heart |
| How does ATP1A2 mutation alter ion affinity? | Knock-in of mutation in cell lines followed by ATPase assay |
| What is the interactome of Na+/K+-ATPase? | Tagged knock-in (e.g., GFP) followed by immunoprecipitation |
How to Study the P-type sodium:potassium-exchanging transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ATPase activity assay | Rate of ATP hydrolysis | Screening for pump inhibitors/activators |
| Patch-clamp | Ion currents generated by the pump | Electrogenic properties and stoichiometry |
| Fluorescence imaging | Intracellular Na+/K+ concentrations | Live-cell monitoring of pump activity |
| Western blot | Protein expression levels of subunits | Validation of knockout or overexpression |
| Immunoprecipitation | Protein-protein interactions | Identification of FXYD subunits |
| CRISPR knockout | Loss-of-function phenotypes | Determining essentiality of subunits |
| CRISPR knock-in | Mutant protein function | Modeling disease-associated mutations |
| RNA-seq | Transcriptional changes | Global effects of pump dysfunction |
ATPase Activity Assays
The classical method to measure Na+/K+-ATPase activity is a coupled enzyme assay that monitors NADH oxidation or phosphate release in the presence of ouabain, a specific inhibitor. This assay can be performed on cell lysates or purified membranes and is used to assess the impact of mutations or drugs on pump function.
Electrophysiology
Patch-clamp and two-electrode voltage-clamp techniques can measure pump currents directly in cells expressing the Na+/K+-ATPase. These methods provide real-time information on ion transport stoichiometry and voltage dependence. They are particularly useful for studying electrogenic properties of the pump.
Fluorescence and Imaging
Fluorescent indicators for Na+ and K+ (e.g., SBFI, PBFI) allow live-cell imaging of ion gradients maintained by the Na+/K+-ATPase. Total internal reflection fluorescence (TIRF) microscopy can visualize subunit trafficking and membrane localization. These techniques are valuable for studying pump regulation in intact cells.
Genetic and Proteomic Approaches
CRISPR/Cas9 gene editing enables the creation of knockout, knock-in, and point-mutation cell lines to dissect subunit-specific functions. Proteomic methods such as immunoprecipitation coupled with mass spectrometry can identify interacting partners and post-translational modifications of the pump. These approaches are essential for understanding the molecular basis of GO:0005391 in health and disease.
How CRISPR Can Be Used to Study GO:0005391 P-type sodium:potassium-exchanging transporter activity
Knockout
CRISPR knockout of ATP1A1 or ATP1B1 in cell lines results in loss of Na+/K+-ATPase activity and is often lethal, underscoring the pump's essential role. Conditional knockout models in mice allow tissue-specific studies, such as in neurons or muscle, to investigate physiological consequences. These models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing disease-associated point mutations (e.g., ATP1A3 D801N) via CRISPR knock-in enables precise modeling of neurological disorders. These models help elucidate how specific residues affect ion binding, phosphorylation, and conformational changes. Point mutations can also be used to study resistance to cardiac glycosides.
Knock-in
Knock-in of tagged versions of ATP1A1 (e.g., GFP or HA) allows visualization and purification of the pump complex. This approach facilitates proteomic analysis of interacting proteins and real-time tracking of pump trafficking. Knock-in of human disease mutations into mouse models provides a platform for testing therapeutics.
Overexpression
Overexpression of wild-type or mutant ATP1A1 in cell lines can be achieved by CRISPR activation or lentiviral delivery. This is useful for studying gain-of-function effects, such as increased pump activity and its impact on cell growth or survival. Overexpression of FXYD proteins can modulate pump kinetics and is used to dissect regulatory mechanisms.
How EDITGENE Supports P-type sodium:potassium-exchanging transporter activity Research
Researchers studying P-type sodium:potassium-exchanging transporter activity-related genes often need to determine whether a candidate gene is causally involved in pump function, ion homeostasis, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for P-type sodium:potassium-exchanging transporter activity research.
Frequently Asked Questions About P-type sodium:potassium-exchanging transporter activity
What is GO:0005391?
GO:0005391 is the Gene Ontology term for P-type sodium:potassium-exchanging transporter activity, the molecular function of the Na+/K+-ATPase, which pumps sodium out and potassium into cells using ATP.
What genes are involved in P-type sodium:potassium-exchanging transporter activity?
The main genes are ATP1A1, ATP1A2, ATP1A3, ATP1A4 (alpha subunits), ATP1B1, ATP1B2, ATP1B3 (beta subunits), and FXYD1-7 (gamma subunits).
What is the function of the sodium pump?
The sodium pump maintains electrochemical gradients by transporting three Na+ ions out and two K+ ions in per ATP hydrolyzed, essential for cell volume, resting potential, and secondary transport.
How is Na+/K+-ATPase activity measured?
It is commonly measured by ATPase activity assays, patch-clamp electrophysiology, or fluorescence imaging of ion concentrations.
What diseases are associated with Na+/K+-ATPase mutations?
Mutations in ATP1A2 and ATP1A3 cause neurological disorders like hemiplegic migraine and alternating hemiplegia; ATP1A1 is linked to hypertension and cancer.
Can CRISPR be used to study Na+/K+-ATPase?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect subunit functions and model diseases.
What is the role of FXYD proteins in Na+/K+-ATPase?
FXYD proteins are regulatory gamma subunits that modulate the pump's affinity for Na+ and K+ in a tissue-specific manner.
How does oxidative stress affect Na+/K+-ATPase?
Oxidative stress, such as H2O2, can inhibit Na+/K+-ATPase activity by oxidizing critical residues, impacting ion homeostasis.
What are cardiac glycosides and how do they relate to GO:0005391?
Cardiac glycosides like digoxin inhibit Na+/K+-ATPase activity and are used to treat heart failure, making the pump a key drug target.
What model systems are used to study Na+/K+-ATPase?
Common models include CRISPR-edited cell lines, knockout mice, and Xenopus oocytes for electrophysiology.
Conclusion
The P-type sodium:potassium-exchanging transporter activity (GO:0005391) is a cornerstone of cellular physiology, driven by the Na+/K+-ATPase. Its intricate mechanism, regulation, and links to human disease make it a compelling subject for biomedical research. Advances in CRISPR gene editing and functional assays continue to unravel the complexities of this pump, offering new avenues for therapeutic intervention. EDITGENE stands ready to support these efforts with tailored CRISPR models and screening services.
References
- 1. Kaplan JH. 2002. Biochemistry of Na,K-ATPase.. Annu Rev Biochem 71:511-35 PMID: 12045105
- 2. Sousa L et al.. 2018. Iron overload impact on P-ATPases.. Ann Hematol 97(3):377-385 PMID: 29307086
- 3. Clarke RJ et al.. 2011. Pumping ions.. Clin Exp Pharmacol Physiol 38(11):726-33 PMID: 21848638
- 4. Chkadua G et al.. 2022. Effect of H(2)O(2) on Na,K-ATPase.. J Bioenerg Biomembr 54(5-6):241-249 PMID: 36331672
- 5. McDonough AA et al.. 2002. Skeletal muscle regulates extracellular potassium.. Am J Physiol Renal Physiol 282(6):F967-74 PMID: 11997312
- 6. Martin DW. 2005. Structure-function relationships in the NA+,K+-pump.. Semin Nephrol 25(5):282-91 PMID: 16139683
- 7. Lingrel JB et al.. 1990. Molecular genetics of Na,K-ATPase.. Prog Nucleic Acid Res Mol Biol 38:37-89 PMID: 2158121
- 8. Tadini-Buoninsegni F et al.. 2008. Charge transfer in P-type ATPases investigated on planar membranes.. Arch Biochem Biophys 476(1):75-86 PMID: 18328799
